Thrombosis Research,
Год журнала:
2023,
Номер
232, С. 77 - 88
Опубликована: Ноя. 6, 2023
Patients
with
inflammatory
bowel
disease
(IBD)
have
an
increased
risk
of
developing
venous
thromboembolic
events,
which
a
considerable
impact
on
morbidity
and
mortality.
Chronic
inflammation
plays
crucial
role
in
the
pathogenesis
thrombotic
events
patients
IBD.
However,
many
unresolved
questions
remain,
particularly
regarding
mechanisms
that
determine
persistent
state
independent
activity.
This
review
explored
gut
microbiota
dysbiosis
intestinal
barrier
dysfunction,
are
considered
distinctive
features
IBD,
determining
pro-thrombotic
tendencies.
Gut-derived
endotoxemia
due
to
translocation
bacterial
lipopolysaccharides
(LPS)
from
intestine
bloodstream
metabolite
trimethylamine-N-oxide
(TMAO)
most
important
molecules
involved
dysbiosis-related
thrombosis.
The
pathogenic
prothrombotic
pathways
linked
LPS
TMAO
been
discussed.
Finally,
we
present
emerging
therapeutic
approaches
can
help
reduce
LPS-mediated
TMAO,
such
as
restoring
eubiosis,
normalizing
function,
counterbalancing
effects
TMAO.
Mediterranean
Diet
(MD),
rich
in
minimally
processed
plant
foods
and
monounsaturated
fats,
but
low
saturated
meat
dairy
products,
represents
one
of
the
most
studied
diets
for
cardiovascular
health.
It
has
been
shown,
from
both
observational
randomized
controlled
trials,
that
MD
reduces
body
weight,
improves
disease
surrogates
such
as
waist-to-hip
ratio,
lipids,
inflammation
markers,
even
prevents
development
fatal
non-fatal
disease,
diabetes,
obesity,
other
diseases.
However,
it
is
unclear
whether
offers
benefits
its
individual
components
or
a
whole.
Furthermore,
limitations
methodology
studies
meta-analyses
have
raised
some
concerns
on
potential
benefits.
also
associated
with
characteristic
changes
intestinal
microbiota,
mediated
through
constituents.
These
include
increased
growth
species
producing
short-chain
fatty
acids,
Clostridium
leptum
Eubacterium
rectale,
Bifidobacteria,
Bacteroides
Faecalibacterium
prausnitzii
species,
reduced
Firmicutes
Blautia
species.
Such
are
known
to
be
favorably
inflammation,
oxidative
status,
overall
metabolic
This
review
will
focus
effects
health
action
gut
microbioma.
Journal of the Canadian Association of Gastroenterology,
Год журнала:
2023,
Номер
6(Supplement_2), С. S9 - S15
Опубликована: Сен. 1, 2023
Abstract
Inflammatory
bowel
disease
(IBD),
consisting
of
Crohn’s
and
ulcerative
colitis,
is
recognized
across
the
world,
though
Canada
has
among
highest
burdens
IBD
in
world.
The
Canadian
Gastro-Intestinal
Epidemiology
Consortium
(CanGIEC)
led
a
six-province
study
that
demonstrated
compounding
prevalence
from
400
per
100,000
2002
to
636
2014.
2023
estimated
at
825
100,000,
meaning
over
320,000
people
are
living
with
IBD.
Prevalence
forecasted
rise
by
2.44%
year
such
1.1%
population,
470,000
Canadians,
will
live
2035.
overall
incidence
30
person-years,
indicating
11,000
Canadians
be
newly
diagnosed
2023.
Incidence
0.58%
up
32.1
rising
propelled
pediatric-onset
IBD,
which
1.23%
15.6
18.0
In
contrast,
rates
adults
seniors
relatively
stable.
Understanding
determinates
expanded
through
prospective
cohort
studies
as
Colitis
Genetic,
Environmental,
Microbial
(CCC-GEM)
project.
Consensus
recommendations
towards
diet,
lifestyle,
behavioural
environmental
modifications
have
been
proposed
international
organizations
goal
optimizing
control
ultimately
preventing
development
Despite
these
efforts,
healthcare
systems
need
prepare
for
number
Frontiers in Nutrition,
Год журнала:
2023,
Номер
9
Опубликована: Янв. 10, 2023
Inflammatory
bowel
diseases
(IBD)
are
chronic,
progressive
and
relapsing
inflammatory
disorders
of
unknown
etiology
that
may
cause
disability
over
time.
Data
from
epidemiologic
studies
indicate
diet
play
a
role
in
the
risk
developing
course
IBD.
It
is
known
group
beneficial
bacteria
was
reduced
IBD
Mediterranean
(MD)-which
defined
as
eating
habits
characterized
by
high
consumption
plant
foods,
mainly
cereals,
vegetables,
fruit
well
olive
oil,
small
portions
dairy
products,
sweets,
sugar
meat
products-affects
gut
microbiota,
enriching
bacteria,
which
support
barrier
function
reduce
inflammation.
Although
several
different
favorable
effects
MD
on
IBD,
adherence
to
patients
generally
low,
including
Basin.
Patients
avoid
many
products
elements
because
there
gastrointestinal
symptoms.
should
be
encouraged
have
healthy
well-balanced
according
individual
tolerance
products.
A
good
option
seems
modified
MD,
changing
hard-to-digest
easy
digest.
International Journal of Molecular Sciences,
Год журнала:
2024,
Номер
25(9), С. 4942 - 4942
Опубликована: Апрель 30, 2024
The
Mediterranean
diet
(MD),
rich
in
minimally
processed
plant
foods
and
monounsaturated
fats
but
low
saturated
fats,
meat,
dairy
products,
represents
one
of
the
most
studied
diets
for
cardiovascular
health.
It
has
been
shown,
from
both
observational
randomized
controlled
trials,
that
MD
reduces
body
weight,
improves
disease
surrogates
such
as
waist-to-hip
ratios,
lipids,
inflammation
markers,
even
prevents
development
fatal
nonfatal
disease,
diabetes,
obesity,
other
diseases.
However,
it
is
unclear
whether
offers
benefits
its
individual
components
or
a
whole.
Furthermore,
limitations
methodology
studies
meta-analyses
have
raised
some
concerns
over
potential
benefits.
also
associated
with
characteristic
changes
intestinal
microbiota,
mediated
through
constituents.
These
include
increased
growth
species
producing
short-chain
fatty
acids,
Clostridium
leptum
Eubacterium
rectale,
Bifidobacteria,
Bacteroides,
Faecalibacterium
prausnitzii
species,
reduced
Firmicutes
Blautia
species.
Such
are
known
to
be
favorably
inflammation,
oxidative
status,
overall
metabolic
This
review
will
focus
on
effects
health
action
gut
microbiota.
Nutrients,
Год журнала:
2024,
Номер
16(9), С. 1286 - 1286
Опубликована: Апрель 25, 2024
(1)
Background:
Numerous
elements
of
the
Mediterranean
diet
(MD)
have
antioxidant
and
anti-inflammatory
qualities.
(2)
Methods:
We
present
a
narrative
review
potential
benefits
dietary
pattern
in
mitigating
aging-related
inflammation
(inflamm-aging)
associated
with
childhood
obesity.
The
mechanisms
underlying
chronic
obesity
are
also
discussed.
A
total
130
papers
were
included
after
screening
abstracts
full
texts.
(3)
Results:
complex
interplay
between
obesity,
inflammation,
related
comorbidities
is
documented.
MD
emerges
as
promising
for
inflammation.
Studies
suggest
that
may
contribute
to
weight
control,
improved
lipid
profiles,
insulin
sensitivity,
endothelial
function,
thereby
reducing
risk
metabolic
syndrome
children
adolescents
(4)
Conclusions:
While
evidence
supporting
effects
pediatric
still
evolving,
existing
literature
underscores
its
preventive
therapeutic
strategy.
However,
adherence
remains
low
among
adolescents,
necessitating
targeted
interventions
promote
healthier
habits.
Future
high-quality
intervention
studies
necessary
elucidate
specific
impact
on
diverse
populations
comorbidities.
Inflammatory Bowel Diseases,
Год журнала:
2024,
Номер
30(Supplement_2), С. S5 - S18
Опубликована: Май 1, 2024
Abstract
Preclinical
human
inflammatory
bowel
disease
(IBD)
mechanisms
is
one
of
5
focus
areas
the
Challenges
in
IBD
Research
2024
document,
which
also
includes
environmental
triggers,
novel
technologies,
precision
medicine,
and
pragmatic
clinical
research.
Herein,
we
provide
a
comprehensive
overview
current
gaps
diseases
research
that
relate
to
preclinical
deliver
actionable
approaches
address
them
with
on
how
these
can
lead
advancements
interception,
remission,
restoration.
The
document
result
multidisciplinary
input
from
scientists,
clinicians,
patients,
funders
represents
valuable
resource
for
patient-centric
prioritization.
This
section
identifies
major
whose
investigation
will
elucidate
pathways
be
targeted
unmet
medical
needs
IBD.
were
identified
following
areas:
genetics,
risk
alleles,
epigenetics;
microbiome;
cell
states
interactions;
barrier
function;
complications
(specifically
fibrosis
stricturing);
extraintestinal
manifestations.
To
gaps,
share
specific
opportunities
basic
translational
scientists
identify
priority
actions.
Journal of the Canadian Association of Gastroenterology,
Год журнала:
2023,
Номер
7(1), С. 97 - 103
Опубликована: Дек. 23, 2023
The
rising
incidence
of
inflammatory
bowel
diseases
(IBD),
including
Crohn's
disease
(CD)
and
ulcerative
colitis
(UC),
specifically
in
the
developing
world,
suggests
an
important
environmental
effect.
Amongst
influences,
dietary
factors,
particularly
adoption
a
westernized
diet,
have
been
noticed.
In
contrast,
Mediterranean
diet
(MED),
characterized
by
high
intake
fruits,
vegetables,
whole
grains,
legumes,
nuts,
olive
oil,
moderate
consumption
animal
ultra
processed
foods,
has
shown
potential
positive
effects
IBD.